![]() 教員業績データベース |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読なし |
表題 | Is Noncurative Hepatic Resection Justified for Advanced Hepatocellular Carcinoma? |
掲載誌名 | 正式名:The American surgeon 略 称:Am Surg ISSNコード:1555982300031348 |
掲載区分 | 国外 |
巻・号・頁 | 84(12),pp.1938-44 |
著者・共著者 | Hai Seikan, Hatano Etsuro, Okada Toshihiro, Uyama Naoki, Suzumura Kazuhiro, Fujimoto Jiro |
発行年月 | 2018/12 |
概要 | It has been obscure whether or not noncurative hepatic resection (Hx) has a favorable impact on the clinical course in patients with advanced hepatocellular carcinoma (HCC). The aim of this study is to clarify the significance of noncurative Hx for advanced HCC. Among 666 consecutive patients undergoing Hx for HCC in our department, 79 patients underwent noncurative Hx. These patients were classified as Group A (presence of macrovascular invasion [MVI]; n = 29), Group B (residual tumors in the remnant liver; n = 37), Group C (residual tumors in the remnant liver with MVI; n = 7), or Group D (residual tumors in the remnant liverwith distant metastasis [with or without MVI]; n = 6). The three-year survival rates were 49.6 per cent in Group A, 30.3 per cent in Group B, 14.3 per cent in Group C, and 0.0 per cent in Group D, respectively (Groups A and Bvs |
PMID | 30606352 |